BioCentury
ARTICLE | Financial News

Cantab gets L5 million from Celtic Pharma

January 26, 2010 1:52 AM UTC

Cantab Biopharmaceuticals Ltd. (Cambridge, U.K.) received a L5 million ($8.1 million) investment from Celtic Pharma Holdings Advisors LLP. Cantab is developing enhanced versions of marketed, off-patent biologics. Cantab will initially focus on hematology candidates, which it will develop to Phase I or Phase II testing before seeking partners. ...